Kenya is among eight African countries that participated in clinical trials for a newly approved malaria treatment, ...

The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic.

CHENNAI: Swiss-pharma major Novartis AG said early this week that its pediatric malaria treatment, Coartem Baby, received regulatory approval from Swissmedic, Switzerland's national medicines ...

Norgine has announced that Swissmedic has approved the registration of IFINWIL (eflornithine) as a monotherapy for treating ...

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants. It ...

Bern, Switzerland – 26 February 2025 – Global biotechnology leader CSL (ASX: CSL) announced today that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization to ...

Granules India enters CDMO business by acquiring Senn Chemicals AG Senn develops and manufactures, peptides and peptides-based applications for its global customers, providing contract research ...

Granules India acquires Senn Chemicals AG, expanding into peptide therapeutics and CDMO capabilities for global growth.

CARBOGEN AMCIS AG, a subsidiary of Dishman Carbogen Amcis Limited, has announced the successful completion of a Swissmedic inspection at its Vionnaz facility in Switzerland. This achievement reaffirms ...

"Swissmedic approval further demonstrates our promise to deliver transformational medicines for patients with serious diseases in our areas of focus," said Emmanuelle Lecomte Brisset, Senior Vice ...

"Swissmedic approval further demonstrates our promise to deliver transformational medicines for patients with serious diseases in our areas of focus," said Emmanuelle Lecomte Brisset, Senior Vice ...

"Swissmedic approval further demonstrates our promise to deliver transformational medicines for patients with serious diseases in our areas of focus," said Emmanuelle Lecomte Brisset, Senior Vice ...